» Articles » PMID: 9131017

Production and Characterization of Human 293 Cell Lines Expressing the Site-specific Recombinase Cre

Overview
Date 1996 Nov 1
PMID 9131017
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

We have constructed 293 cell lines expressing the site-specific Cre recombinase from bacteriophage P1, that acts on a 34 bp target sequence called loxP. Stably transformed cells were obtained by transfection with a plasmid containing Cre and a selectable marker under the control of viral promoters. The resulting 293Cre cell lines could be used to induce expression from adenovirus vectors containing reporter genes under the control of a Cre responsive "molecular switch." High efficiency recombination was observed for Ad viral DNA containing loxP sites. The Cre expressing cell lines described here are likely to be useful for several purposes: For expression of toxic gene products from Cre inducible viral vectors, to induce recombination between loxP sites in transfected plasmids, and to induce deletions or rearrangements of genes defined by loxP sites in viral genomes.

Citing Articles

Adenoviral Vector-Based Vaccine Expressing Hemagglutinin Stem Region with Autophagy-Inducing Peptide Confers Cross-Protection Against Group 1 and 2 Influenza A Viruses.

Wang W, Sayedahmed E, Alhashimi M, Elkashif A, Gairola V, Murala M Vaccines (Basel). 2025; 13(1).

PMID: 39852874 PMC: 11769558. DOI: 10.3390/vaccines13010095.


Development of NP-Based Universal Vaccine for Influenza A Viruses.

Sayedahmed E, Elshafie N, Dos Santos A, Jagannath C, Sambhara S, Mittal S Vaccines (Basel). 2024; 12(2).

PMID: 38400140 PMC: 10892571. DOI: 10.3390/vaccines12020157.


Apolipoprotein A-I vascular gene therapy reduces vein-graft atherosclerosis.

Bi L, Wacker B, Komandur K, Sanford N, Dichek D Mol Ther Methods Clin Dev. 2023; 30:558-572.

PMID: 37693942 PMC: 10482902. DOI: 10.1016/j.omtm.2023.08.018.


Impact of an autophagy-inducing peptide on immunogenicity and protection efficacy of an adenovirus-vectored SARS-CoV-2 vaccine.

Sayedahmed E, Araujo M, Silva-Pereira T, Chothe S, Elkashif A, Alhashimi M Mol Ther Methods Clin Dev. 2023; 30:194-207.

PMID: 37502665 PMC: 10299838. DOI: 10.1016/j.omtm.2023.06.009.


Utilizing the LoxP-Stop-LoxP System to Control Transgenic ABC-Transporter Expression In Vitro.

Esobi I, Olanrewaju O, Echesabal-Chen J, Stamatikos A Biomolecules. 2022; 12(5).

PMID: 35625607 PMC: 9138957. DOI: 10.3390/biom12050679.